Zenostin-CV Capsule IR
Images are for reference. Actual packaging may vary.
1 units • OtherPrescription requiredSchedule H
Zenostin-CV Capsule IR
Rosuvastatin (20mg) + Clopidogrel (75mg)
₹110.00
1 units • Other
A valid prescription is required for this medicine.
1
Delivery
Safe & Secure
Easy Returns
24/7 Support
SMARTER CARE
A little guidance.
A better choice.
Haven’t found an alternative? A health advisor can help you understand what to do next.
No matching alternative found
We haven't found a cheaper matching alternative in our catalogue right now. Our health advisors can help you explore other options.
Active composition
Rosuvastatin 20 mg
+1 more active ingredient
How It Works
Rosuvastatin inhibits HMG-CoA reductase, decreasing cholesterol synthesis in the liver and increasing LDL receptor expression.
Clopidogrel irreversibly inhibits the P2Y12 component of ADP receptors on platelets, preventing platelet activation and aggregation.
Medicine Strength
20 mg
All Active Ingredients
Rosuvastatin20 mg
Clopidogrel75 mg
Uses & Benefits
Medical applications
Cholesterol
Zenostin-CV Capsule IR is a combination pharmaceutical formulation containing Rosuvastatin 20 mg and Clopidogrel 75 mg, designed for the management of cardiovascular conditions. Rosuvastatin, a potent HMG-CoA reductase inhibitor, effectively lowers low-density lipoprotein cholesterol (LDL-C) and triglycerides while modestly increasing high-density lipoprotein cholesterol (HDL-C), thereby reducing the risk of atherosclerotic cardiovascular disease.
Read full descriptionShow less
Clopidogrel, an antiplatelet agent, irreversibly inhibits the P2Y12 component of ADP receptors on platelet surfaces, preventing platelet aggregation and thrombus formation. This combination is indicated for patients at high risk of cardiovascular events, including those with a history of myocardial infarction, stroke, or established peripheral arterial disease, where both lipid-lowering and antiplatelet effects are warranted.
Zenostin-CV Capsule IR is administered orally, with dosing tailored to individual patient profiles and clinical response. The fixed-dose combination enhances patient compliance by simplifying therapy. Caution is advised in patients with hepatic impairment, bleeding disorders, or concomitant use of other anticoagulants. Regular monitoring of liver function tests, lipid profiles, and platelet counts is recommended to ensure therapeutic efficacy and safety.
Adverse effects may include myalgia, gastrointestinal disturbances, and increased bleeding risk. Zenostin-CV Capsule IR should be used under strict medical supervision.
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Safety information not available for this product. Please consult your doctor or pharmacist.
Customer Reviews
0 reviews for Zenostin-CV Capsule IR
